FDA Adverse Event Injury Summary report: N

MOSAIC MITRAL BIOPROSTHETIC HEART VALVE

MDR report key: 7161158 · Received January 3, 2018

Report

Report Number
2025587-2018-00032
Event Type
Injury
Date Received
January 3, 2018
Date of Event
September 30, 2017
Report Date
January 3, 2018
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
LWR
PMA / PMN Number
P990064
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IR
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CITATION: HAJI ZEINALI AM, ABBASI K, SAHEB JAM M, YAZDANI S, MORTAZAVI SH. TRANSCATHETER HEART VALVE IN VALVE IMPLANTATION WITH EDWARDS SAPIEN BIOPROSTHETIC VALVE FOR DIFFERENT DEGENERATED BIOPROSTHETIC VALVE POSITIONS (FIRST IRANIAN VIV REPORT WITH MID-TERM FOLLOW UP). J CARDIOVASC THORAC RES 2017;9(3):152-157. DOI: 10.15171/JCVTR.2017.26 EARLIEST DATE OF E-PUBLISH/PUBLISH USED FOR EVENT DATE. NO UNIQUE DEVICE IDENTIFIER (SERIAL/LOT) NUMBERS WERE PROVIDED; WITHOUT THIS INFORMATION, IT CANNOT BE DETERMINED WHETHER THIS EVENT HAS BEEN PREVIOUSLY REPORTED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION VIA LITERATURE REVIEW REGARDING OUTCOMES AFTER THE IMPLANT OF A NON MEDTRONIC BALLOON EXPANDABLE TRANSCATHETER AORTIC VALVE IMPLANTED VALVE-IN-VALVE INTO FAILED SURGICAL VALVES. ALL DATA WERE COLLECTED FROM A SINGLE CENTER BETWEEN 2015 AND 2016. THE STUDY POPULATION INCLUDED 5 PATIENTS, 3 OF WHICH HAD PREVIOUSLY BEEN IMPLANTED WITH A MEDTRONIC DEVICE. SERIAL NUMBERS WERE NOT PROVIDED. MEDTRONIC RECEIVED INFORMATION THAT (B)(6) FEMALE PATIENT HAD BEEN IMPLANTED WITH A 31MM MOSAIC BIOPROSTHETIC VALVE IMPLANTED INTO THE TRICUSPID POSITION. ONE YEAR POST IMPLANT, THE VALVE WAS REPLACED IN A VALVE-IN-VALVE PROCEDURE DUE TO TRICUSPID REGURGITATION AND STENOSIS. NO ADDITIONAL ADVERSE PATIENT EFFECTS OR PRODUCT PERFORMANCE ISSUES WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
5870 MOSAIC MITRAL BIOPROSTHETIC HEART VALVE HEART-VALVE, NON-ALLOGRAFT TISSUE LWR MEDTRONIC HEART VALVES DIVISION 310_MOSAIC

Patients

Seq Age Sex Outcome Treatment
1 59 YR Required Intervention